Literature DB >> 17826316

Gated myocardial perfusion imaging for the assessment of left ventricular function and volume: from SPECT to PET.

Tali Sharir.   

Abstract

Mesh:

Year:  2007        PMID: 17826316     DOI: 10.1016/j.nuclcard.2007.07.001

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  20 in total

1.  Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease.

Authors:  D B Pryor; F E Harrell; K L Lee; R A Rosati; R E Coleman; F R Cobb; R M Califf; R H Jones
Journal:  Am J Cardiol       Date:  1984-01-01       Impact factor: 2.778

2.  Quantitative analysis of regional motion and thickening by gated myocardial perfusion SPECT: normal heterogeneity and criteria for abnormality.

Authors:  T Sharir; D S Berman; P B Waechter; J Areeda; P B Kavanagh; J Gerlach; X Kang; G Germano
Journal:  J Nucl Med       Date:  2001-11       Impact factor: 10.057

3.  Gated cardiac 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardiography-gated 18F-FDG PET.

Authors:  Aliasghar Khorsand; Senta Graf; Harald Eidherr; Wolfgang Wadsak; Kurt Kletter; Heinz Sochor; Ernst Schuster; Gerold Porenta
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

4.  Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction.

Authors:  T Sharir; G Germano; X Kang; H C Lewin; R Miranda; I Cohen; R D Agafitei; J D Friedman; D S Berman
Journal:  J Nucl Med       Date:  2001-06       Impact factor: 10.057

5.  Validation of an evaluation routine for left ventricular volumes, ejection fraction and wall motion from gated cardiac FDG PET: a comparison with cardiac magnetic resonance imaging.

Authors:  Wolfgang M Schaefer; Claudia S A Lipke; Bernd Nowak; Hans Juergen Kaiser; Arno Buecker; Gabriele A Krombach; Udalrich Buell; Harald P Kühl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-15       Impact factor: 9.236

6.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

7.  Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.

Authors:  Wolfgang M Schaefer; Claudia S A Lipke; Bernd Nowak; Hans-Juergen Kaiser; Patrick Reinartz; Arno Buecker; Gabriele A Krombach; Udalrich Buell; Harald P Kühl
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

8.  End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function.

Authors:  A W Hamer; M Takayama; K A Abraham; A H Roche; A R Kerr; B F Williams; M C Ramage; H D White
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

9.  Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT.

Authors:  Timothy M Bateman; Gary V Heller; A Iain McGhie; John D Friedman; James A Case; Jan R Bryngelson; Ginger K Hertenstein; Kelly L Moutray; Kimberly Reid; S James Cullom
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

10.  Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease.

Authors:  Uchechukwu K Sampson; Sharmila Dorbala; Atul Limaye; Raymond Kwong; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2007-02-26       Impact factor: 24.094

View more
  1 in total

Review 1.  Facts and figures on CAD assessment with SPECT and PET-CT.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.